Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Did The 2017 Biosimilar Industry Pave The Way For A Productive 2018?

28 December 2017

Open

Pharmacovigilance, traceability and building trust in biosimilar medicines

21 December 2017

Open

Manufacturing cost transparency could combat pricing criticism, says expert

2 November 2017

Open

European report calms common concerns

15 September 2017

Open

Europäer zahlen zu viel für Pillen

18 July 2017

Open

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Open

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Open

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Open

Biosimilars at work: Access. Experience. Science.

1 April 2017

Biosimilar medicines are a part of today’s therapeutic armamentarium – […]

Read more

Access to Medicines at Sustainable Price: Pharma Industry and Governments Transforming Challenges into Opportunities

23 March 2017

Open

Subscribe to our newsletter